|
TTD
Drug ID:
DNC011857
Drug
Information |
Name | FLUMEZAPINE | Synonyms | FLUMEZAPINE | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | Target | Dopamine D1 receptor |  | Inhibitor | [1] | Dopamine D2 receptor |  | Inhibitor | [2] | Dopamine D3 receptor |  | Inhibitor | [1] | Dopamine D4 receptor |  | Inhibitor | [1] | Dopamine D5 receptor |  | Inhibitor | [1] | Muscarinic acetylcholine receptor M1 |  | Inhibitor | [2] | Muscarinic acetylcholine receptor M2 |  | Inhibitor | [2] | Muscarinic acetylcholine receptor M3 |  | Inhibitor | [2] | Muscarinic acetylcholine receptor M4 |  | Inhibitor | [2] | Muscarinic acetylcholine receptor M5 |  | Inhibitor | [2] | Ref 1 | J Med Chem. 1982 Oct;25(10):1133-40.Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems. To Reference | Ref 2 | J Med Chem. 1989 Dec;32(12):2573-82.Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|